Medical network - on July 19th, recently, in the "path to minimally invasive medical technology innovation in China" conference, Shanghai ease medical technology co., LTD., founder and chief scientist NieGongLin said: "with the international medical level of domestic high-end devices, compared to domestic low-end products, will eventually fall in price. Such a predicament, often make excellent enterprise have a headache, because they stand in technology and foreign capital enterprises in the same horizontal line, is the price still have to compete with domestic low-end devices."
At the beginning of the reform and opening up, the ministry of health for the protection of domestic medical equipment, domestic and international products are grouped in the tender, the so-called "detained". Ten years later, the original heart, to protect the domestic brand development but the status of the domestic high-end YiXie awkward.
In the field of minimally invasive interventional devices, because of the influence of the bidding policy, domestic high-end interventional devices have been can't get a good application. Surgery, radiation therapy, medication, minimally invasive surgery is the four means of cancer treatment. Eu health economics statistics show that the cost of tumor minimally invasive surgery, 20% lower than conventional surgery, only 1/5 to 1/10 of the radiation and chemotherapy, but the domestic use of minimally invasive cancer patients is only 7% ~ 10%.
NieGongLin admits: "small trauma, low price of minimally invasive interventional treatment ought is a standing army in tumor treatment, but the actual use not many. Clinical popularization, patient acceptance is the cause of the minimally invasive surgery clinical use has space. More importantly, the lack of professional talents at the grass-roots level. Not patients don't want to use, but there is no ability to use hospital. Especially in some basic-level hospitals, tumor minimally invasive surgery may not be introduced."
Break the grouping, more multinational drug companies reduce the price
In 2015, our country medical equipment enterprises above designated size product sales accounted for 14% of the total scale of medicine industry, domestic medical equipment in the field of low-end medical equipment accounted for over 60%. It is obvious that the main force of domestic medical more concentrated in the low-end market.
Innovation, has always been a weakness of domestic medical equipment development. With the industry experts pointed out: "in generic and imitating development way, completed the general medical equipment from historical mission in China, especially in the field of low-end medical apparatus and instruments, domestic medical equipment have generally accounted for more than 60% of market share."
Recently held in medical equipment bidding with no clear group, zhejiang province, large Angle of multi-functional cavity mirror stapling and Johnson &johnson, medtronic directly in the stapling the review of the bidding.
SGS to carry out the contrast tests in Europe, domestic large Angle of multi-functional stapling suture strength of cavity mirrors than imported products 10%, titanium nail forming defective rate less than 30% of imported products, equipment, fire force 19% lower than the imported product.
In product quality comparable to multinational drug companies, and even an advantage, in order to avoid being kicked out in the tender, multinational medical equipment giant also can directly to the bid price 30% lower.
According to reporter understanding, in the bidding practice, general international equipment giant is done only about 5% of the price cut, but meet the domestic large Angle of multi-functional cavity mirror stapling, they also have a lot of pressure.
The personage inside course of study points out, cancel the grouping, bid directly, for domestic high-end medical equipment enterprises, more good.
NieGongLin pointed out: "is the most need of minimally invasive surgical treatment of patients at the local level. In February 2017, the national cancer center released data, China's latest cancer results show that the small city of cancer mortality is higher, because they lack within easy reach of the treatment."
This year, ease health under the state development planning commission and ministry of science and technology support, launched the "321 project - / county hospital cancer prevention and control technique expansion plan", in the three years time, in at least ten province construction 20 clinical demonstration training base, at least 100 in the whole country and prefecture or county hospital popularization tumor minimally invasive surgery technology, make its have the ability to tumor minimally invasive surgery and to explore from the perspective of enterprise to help promote national "of a serious illness that county" "classification and treatment" policy implementation.
NieGongLin stressed: "we hope that by convened the national leading group for tumor of experts in the field of minimally invasive surgery, called for provincial hospital experts training group, the national planning committee of the provincial health is responsible for the screening of conditional cities and counties in the hospital and the leader, to organize the training, we provide the required equipment. Through continuous training, improve doctors use the confidence of the domestic medical devices."
Cooperative r&d can help break the dilemma
In 2015, ease medical launched 60 degrees for the first time in the global big corner cutting anastomat multi-functional cavity mirror, and the world the one-handed operation of stapling.
For research and development success, NieGongLin experience to share, cooperation development is crucial, he stressed: "medical devices for clinical services, only good in clinical use, this equipment will have stronger vitality. Product development without clinical. Let clinical specialists are involved, the initiative to communicate with the r&d team, formed a new mode of interaction and innovation, is a way out of domestic medical equipment innovation. Clinical experts as the first signature of product patent, after the industrialization of scientific research achievements to let them participate in profit sharing."
In addition, with the international medical equipment enterprise cooperation is also the extension of the model. According to reporter understanding, in the field of cavity mirror systems product line, ease health through technical cooperation with international leading brands, product line has been the latest generation technology, 4 k cavity mirror technology and patent introduced into China.
In energy knife line, ease of medical ultrasonic knife system has entered the stage of registration, clinical trials carried out in the early stage of the animals, and Johnson &johnson products contrast test, cutting time and burst pressure, but the product service life is longer.
NieGongLin said: "IN the current market environment, because MADE IN CHINA products IN overseas markets for the complete independent pricing power has certain limitations, a better business model is to ease the medical technology transfer to European and American developed countries well-known high-quality medical equipment company. Use their brand and marketing channels form the size of the market quickly, to help us grow into an international enterprise."
|
